在体内注射佩格菲尔格拉斯蒂姆用于化疗诱导的中性质衰竭预防:当前状态
Ivo Abraham1, Jeffrey Crawford2, Lee Schwartzberg3
1Center for Health Outcomes and Pharmacoeconomic Research Center, R. Ken Coit College of Pharmacy, University of Arizona, Tucson, AZ, USA; The University of Arizona Cancer Center, Tucson, AZ, USA.
Cancer treatment and research communications
|June 12, 2024
概括
用于佩格菲尔格拉斯蒂姆的体内注射器 (OBI) 装置是安全有效的,改善了患者在癌症护理中的坚持和方便. 这些设备提供了成本效益和扩展的访问,提高了整体的患者体验.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学 是一个学科.
- 医疗器械 医疗器械
背景情况:
- 骨髓抑制是癌症治疗的一个重大挑战,往往导致严重的并发症.
- 预防性颗粒细胞殖民地刺激因子,如佩格菲尔格拉斯蒂姆,对于减轻化疗诱导的中性质衰竭至关重要.
- 在体内注射器 (OBI) 装置代表了格菲尔格拉斯蒂姆输送的进步.
研究的目的:
- 为了评估体内注射器 (OBI) 装置在癌症患者中用于菲拉斯蒂姆的作用和有效性.
- 在有效性,安全性,患者偏好和经济因素方面,比较OBI设备与传统预装注射器.
- 评估OBI设备在癌症治疗中的整体价值主张.
主要方法:
- 使用全面的搜索策略进行了叙事审查.
- 搜索的数据库包括PubMed和AI驱动的直观搜索工具.
- 综合了OBI设备,它们的管理和患者结果的现有文献中的证据.
主要成果:
- 在佩格菲尔格拉斯蒂姆 (pegfilgrastim) 管理过程中,OBI设备显示出有效性和安全性.
- 优势包括减少诊所访问,增强患者的坚持,以及改善便利性.
- 研究表明,成本效益和扩展的访问,与积极的患者和提供者偏好.
结论:
- 在癌症护理中,OBI设备为患者的治疗结果,方便性和资源优化提供了显著的好处.
- 生物类似的OBIs的出现可能会进一步提高成本效益和采用.
- 技术进步和正在进行的研究支持OBI设备在癌症治疗中的更广泛接受.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
159
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
159
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
194
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
194
Bone Marrow Sampling and Transplants
324
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
324


